News from IntelligentMDx

Sep 10, 2013, 16:28 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx Receives FDA Clearance for IMDx Flu A/B and RSV for Abbott m2000 assay

 IntelligentMDx announced today that the U.S. Food and Drug Administration (FDA) has cleared its automated molecular diagnostic test that...

Apr 15, 2013, 08:28 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx anuncia la Marca CE para un test de detección de la gripe A, B y virus respiratorio sincitial

- IntelligentMDx anuncia la Marca CE para un test de detección y diferenciación de la gripe A, gripe B y virus respiratorio sincitial con...

Apr 15, 2013, 08:28 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx gibt CE-Kennzeichnung eines Tests zum Nachweis und zur Differenzierung von Influenza A, Influenza B und respiratorischem Synzytialvirus in Echtzeit-System Abbott m2000 bekannt

IntelligentMDx (IMDx) gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für einen gemultiplexten Echtzeit-PCR-Test zum Nachweis...

Apr 15, 2013, 08:28 ET
Jan 08, 2013, 04:01 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IMDx schließt Vereinbarung mit QIAGEN zur Entwicklung molekularer Tests

IMDx (in Privatbesitz) gab heute bekannt, dass das Unternehmen eine mehrjährige Entwicklungs- und Lizenzvereinbarung mit QIAGEN (NASDAQ:...

Jan 07, 2013, 19:56 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx Enters into an Agreement with QIAGEN to Develop and Manufacture Molecular Tests

 IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN...

Jan 07, 2013, 16:00 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IMDx llega a un acuerdo con QIAGEN para desarrollar test moleculares

IMDx (de propiedad privada) ha anunciado hoy que ha entrado en un acuerdo de desarrollo de múltiples años y acuerdo de licencia con...

Jan 07, 2013, 16:00 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IMDx conclut un accord avec QIAGEN pour le développement de tests moléculaires

IMDx (société privée) a annoncé aujourd'hui avoir conclu un accord de développement et de licence de plusieurs...

Dec 19, 2012, 14:47 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx Names Maurice Exner, Ph.D. Vice President of Research and Development

CAMBRIDGE, Mass., Dec. 19, 2012 /PRNewswire --  IntelligentMDx (IMDx) is pleased to announce that Maurice Exner, Ph.D., has joined IMDx as...

Jul 19, 2012, 14:47 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2

 IntelligentMDx (IMDx) announced today that it has obtained CE-marking for its fourth automated, high-throughput molecular test designed and...

May 15, 2012, 10:48 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve women's health and prenatal care

 IntelligentMDx (IMDx) announced today that it has obtained CE-marking for a new automated, high-throughput, qualitative in vitro diagnostic...

Mar 27, 2012, 10:16 ET

IntelligentMDx präsentiert Entwicklung von zwei Testkits mit CE-Kennzeichnung auf dem 22. Europäischen Kongress für klinische Mikrobiologie und Infektionskrankheiten (ECCMID)

IntelligentMDx (IMDx), ein Molekulardiagnostikunternehmen, das die Entwicklung PCR-basierter Diagnosetests mithilfe seiner proprietären...

Mar 27, 2012, 10:16 ET

IntelligentMDx presenta el desarrollo de dos ensayos con la Marca CE

IntelligentMDx presenta el desarrollo de dos ensayos con la Marca CE en el 22nd Annual European Congress of Clinical Microbiology and...

Mar 27, 2012, 10:16 ET
Mar 06, 2012, 13:49 ET
IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases.  (PRNewsFoto/IntelligentMDx)

Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch

 Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx (IMDx), has been named a 2012 Woman to Watch by Mass High Tech.  This is the 9th...

Nov 15, 2011, 17:41 ET

Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business

Dr. Alice Jacobs, CEO of IntelligentMDx (IMDx), was named Best Entrepreneur for a non-service business of up to 100 employees in the eighth annual...

Sep 21, 2011, 10:22 ET

IntelligentMDx (IMDx) Introduces a CE-Marked Automated Molecular Test for the Detection of Vancomycin Resistance Genes vanA and vanB Most Commonly Found in Vancomycin-Resistant Enterococci

IntelligentMDx (IMDx) announced today that it has received CE-Mark for its second automated molecular test for the Abbott FDA cleared m2000...

Mar 24, 2010, 07:33 ET

IntelligentMDx (IMDx) Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay to be Authorized for Use on Multiple Instruments in Commercial Laboratories

IMDx announced today that its IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay has been granted Emergency Use Authorization (EUA) from the U.S....

Jan 08, 2009, 07:33 ET

Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed

IntelligentMDx a developer and manufacturer of proprietary nucleic acid assays, today announced that verification studies of the IntelligentMDx BK...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge